Ezra Cohen to Anticarcinogenic Agents
This is a "connection" page, showing publications Ezra Cohen has written about Anticarcinogenic Agents.
Connection Strength
0.490
-
The next phase of chemoprevention research. Cancer Prev Res (Phila). 2011 Mar; 4(3):293-5.
Score: 0.363
-
Erlotinib and the Risk of Oral Cancer: The Erlotinib Prevention of Oral Cancer (EPOC) Randomized Clinical Trial. JAMA Oncol. 2016 Feb; 2(2):209-16.
Score: 0.128